American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Perales
    Perales
  5. Tallman
    Tallman
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Palomba
    Palomba
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (4000)
  2. Hematologic Malignancies, Division of (3803)
  3. Center for Hematologic Malignancies (3680)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1343)
  6. Sloan Kettering Institute Faculty (1075)
  7. Bone Marrow Transplant (988)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (955)
  9. Lymphoma (941)
  10. Tow Center for Developmental Oncology (TCDO) (882)
Search Within
Formats
  1. Meeting Abstract (4150)
  2. Journal Article (1257)
  3. Research Letter (46)
  4. Review (44)
  5. Editorial (35)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (4000)
  2. Hematologic Malignancies, Division of (3803)
  3. Center for Hematologic Malignancies (3680)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1343)
  6. Sloan Kettering Institute Faculty (1075)

More Groups

People
  1. Sergio Giralt (348)
  2. Andrew Zelenetz (341)
  3. Ross Levine (316)
  4. Miguel-Angel Perales (312)
  5. Martin Tallman (301)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (64)
  2. 2024 (428)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (5174)
  2. Blood Advances (331)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5555)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Similar incidence of typhlitis in patients receiving various doses of daunorubicin or idarubicin as induction for acute myeloid leukemia
    Meeting Abstract

    Seddon, A. N.; Michael, A. G.; Adel, N. G.; Tallman, M. S.; Akin, O.; Chaim, J.; Drill, E.
    Blood (2014)

    Fulltext@MSK | Save
  • Chemotherapy-induced senescence reprograms lymphoma and leukemia cells into latent cancer stem cells that are susceptible to conceptually novel treatments
    Meeting Abstract

    Schmitt, C. A.; Milanovic, M.; Daebritz, H.; Zhao, Z.; Trumpp, A.
    Blood (2014)

    Fulltext@MSK | Save
  • A Cutaneous Lymphoma International Consortium 'CLIC' study of prognostic parameters in advanced stages of mycosis fungoides and Sezary syndrome: Progress towards establishing a prognostic index to augment clinical staging
    Meeting Abstract

    Scarisbrick, J. J.; Quaglino, P.; Vermeer, M.; Whittaker, S.; Wood, G. S.; Duvic, M.; Prince, M.; Horwitz, S. M.; Hoppe, R. T.; Porcu, P.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Myeloablative double-unit cord blood transplantation (CBT) in pediatric patients with high-risk acute leukemia demonstrates encouraging disease-free survival with both TBI and chemotherapy-only-based conditioning
    Meeting Abstract

    Scaradavou, A.; Lubin, M. N.; Hilden, P.; Boulad, F.; Curran, K. J.; Kobos, R.; Prockop, S. E.; O'Reilly, R. J.; Tonon, J. A.; Byam, C.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Safe and effective treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL) and low baseline platelet counts with belinostat
    Meeting Abstract

    Savage, K. J.; Horwitz, S. M.; Zinzani, P. L.; Van Hoof, A.; Assouline, S. E.; Bhat, G.; Choi, M. R.; Allen, L. F.; Ben-Yehuda, D.; Jurczak, W.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Interim safety analysis: A phase I trial of high dose therapy and autologous stem cell transplantation followed by infusion of chimeric antigen receptor modified T-cells (19-28z CAR-T) directed against CD19+B-cells for relapsed and refractory aggressive B cell non-Hodgkin lymphoma (B-NHL)
    Meeting Abstract

    Sauter, C. S.; Riviere, I.; Bernal, Y. J.; Wang, X. Y.; Purdon, T. J.; Yoo, S.; Moskowitz, C. H.; Giralt, S.; Matasar, M. J.; Curran, K. J.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Double-unit cord blood (CB) transplantation (DCBT) combined with haplo-identical CD34+selected peripheral blood stem cells (PBSC) is associated with enhanced neutrophil recovery, universal haplo rejection and frequent pre-engraftment syndrome
    Meeting Abstract

    Sanchez, M. E.; Ponce, D. M.; Lauer, E. J.; Lubin, M. N.; Barone, J.; Byam, C.; Dahi, P. B.; Meagher, R.; Castro-Malaspina, H.; Jakubowski, A. A.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Allogeneic transplantation for chronic myelomonocytic leukemia (CMML) is associated with high disease-free survival even in the setting of high-risk disease
    Meeting Abstract

    Sanchez, M. E.; Abbi, K. K. S.; Tamari, R.; Jakubowski, A.; Papadopoulos, E. B.; Devlin, S. M.; Shi, W. J.; Sauter, C. S.; Barker, J. N.; Boulad, F.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Characterization of DLBCL-derived exosomes and investigation of their biological properties
    Meeting Abstract

    Rutherford, S. C.; Sawh, S.; Saxena, A.; Ishii, J.; Dominguez, M. D.; Chambwe, N.; Lopes, E. C.; Agirre, X.; Betel, D.; Shaknovich, R.
    Blood (2014)

    Fulltext@MSK | Save
  • Molecular determinants of decitabine response in chronic myelomonocytic leukemia
    Meeting Abstract

    Rossi, A.; Meldi, K.; Martinez, A. B. V.; Abdel-Wahab, O.; Micol, J. B.; Qin, T. T.; Buchi, F.; Masala, E.; Sanna, A.; Allione, B.; more...
    Blood (2014)

    Fulltext@MSK | Save